Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Dosage Forms × Clear all

Phase

Status

Completed 16 Unknown 2 Terminated 2 Recruiting 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1

Interventions

pembrolizumab 369 Carboplatin 264 Cyclophosphamide 255 Nivolumab 250 Paclitaxel 209 Specimen Handling 206 Magnetic Resonance Spectroscopy 203 Cisplatin 202 Radiotherapy 187 Dexamethasone 157 Gemcitabine 153 durvalumab 148 Biopsy 144 atezolizumab 133 Lenalidomide 122 Rituximab 116 Doxorubicin 116 Bevacizumab 114 Docetaxel 113 Ipilimumab 109 Radiosurgery 101 Oxaliplatin 99 Capecitabine 99 Radiation 98 Fluorouracil 96 fludarabine 95 Etoposide 94 venetoclax 93 Prednisone 92 Pemetrexed 88

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05309668 2025-12-18

SPRINKLE

AstraZeneca

Phase 1/2 Active not recruiting

36 enrolled 37 charts

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡